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 It would be desirable to understand why anxiety disorders are highly comorbid 
with mood disorders yet distinguished by drug response and symptom 
structure. 
 Current theoretical frameworks distinguish GAD from PD by in terms of 
sensitivity to complex versus simple threat. 
 We tested this hypothesis using behavioural and self-report measures of threat-
sensitivity in a case-control study with GAD, PD, MDD and healthy control 
groups.  
 Our findings oppose the simple/complex threat dichotomy, instead suggesting 
elevated sensitivity to physical threat differentiates panic disorder from mood 
disorders, whereas elevated sensitivity to social threat is a risk factor for 
affective disorders in general. 
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Background: Anxiety disorders are highly comorbid with major depression but differ 
in their symptom profiles and pharmacological responses. Threat-sensitivity may 
explain such differences, yet research on its relationship to specific disorders is lacking. 
Methods: One-hundred patients (71 women) and 35 healthy controls (23 women) were 
recruited. Thirty-five had Panic Disorder (PD), 32 had Generalized Anxiety Disorder 
(GAD) and 33 Major Depressive Disorder (MDD). Threat-sensitivity was measured via 
behaviour (Joystick Operated Runway Task; JORT) and self-report (Fear Survey 
Schedule; FSS). 
Results: Behavioural sensitivity to simple threat was higher in females compared to 
males (p=.03). Self-reported sensitivity to simple threat (FSS Tissue Damage Fear) was 
higher in PD patients compared to other groups (p≤.007) and in GAD patients compared 
to controls (p=.02). Behavioural sensitivity to complex threat was higher in females 
than males (p=.03) and a group by sex interaction (p=.01) indicated that this difference 
was largest in PD patients. Self-reported sensitivity to complex threat (FSS Social Fear) 
was higher in all patients compared to controls (p≤.001). Females scored higher than 
males on FSS Tissue Damage Fear and FSS Social Fear). 
Conclusions: Our findings oppose the simple/complex threat dichotomy, instead 
suggesting elevated sensitivity to physical threat differentiates anxiety disorders from 
MDD, whereas elevated sensitivity to social threat is associated with both anxiety 
disorders and MDD. 
 
Keywords:  
Affective disorders; Panic Disorder; Generalized Anxiety Disorder; Personality; 
Joystick Operated Runway Task 
 
1. Introduction 
Approximately 14.0% of the EU population suffer from an anxiety disorder and 6.9% 
from major depression disorder (MDD; Wittchen et al. 2011), suggesting that these 
two categories of affective illness comprise a significant human disease burden. 
Understanding the causal basis of these disorders is therefore an important goal of 
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psychiatry but this research effort is complicated by sex-specificity and comorbidity, 
as affective disorders are approximately twice as common in women as men (McLean 
et al. 2011; Baxter et al. 2014), and also display high lifetime comorbidity (up to 
80%; Gorwood, 2004; Wray et al. 2018).  
A further complication arises from findings that such disorders are 
heterogeneous in their symptom profiles and pharmacological responses. For 
example, MDD typically responds best to antidepressant drugs (Cipriani et al. 2018) 
whereas benzodiazepines tend to be the most efficacious treatment for anxiety 
disorders (Starcevic, 2014). However, this is not the case for all anxiety disorders, as 
Panic Disorder (PD) is typically treated with antidepressants (Bandelow, Baldwin & 
Zwanzger; 2013) – this suggests a differentiation of anxiety and panic disorders, 
which also has been shown to have a neuropsychological basis (Gray & McNaughton, 
2000). Conversely, some new treatment manuals for anxiety disorders (not 
exclusively for PD) suggest prescribing antidepressants before benzodiazepines (e.g., 
Andrews et al., 2016). 
This phenotypic complexity could be interpreted as suggesting that the 
anxiety/depression distinction is arbitrary, but this seems unlikely as it echoes the 
long-standing clinical observation which relates anxiety disorders to threat and 
depression to loss (e.g., Freud, 1957). This notion is also supported by data showing 
that patients with anxiety disorders exhibit an attentional bias towards threat (Cisler & 
Koster, 2010), but to date there is a lack of direct, case-controlled, multi-method 
evidence to show that elevated threat-sensitivity distinguishes anxiety disorders from 
depression. Here we sought to address this gap in the literature by comparing the 
behavioural and self-reported threat-sensitivity of anxiety disorder patients to those of 
depressed patients and healthy controls. Given that female mammals tend to be more 
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sensitive to threat than males (e.g., Day et al. 2016) and anxiety disorders are more 
common in women than in men (Kessler et al., 2011; Tolin and Foa, 2006), we also 
sought to explore sex differences in threat sensitivity. 
We tested whether male and female patients with different anxiety disorders 
display differential sensitivity to various threat categories and, in turn, are more 
sensitive to threat than MDD patients. Theoretical accounts based on rodent work 
posit that PD reflects altered functioning in relatively basic, fear-mediating systems in 
the mid-brain that govern responses to threats that can be simply avoided 
(McNaughton & Corr, 2004). Simple threats are hypothesised to elicit activity in the 
Fight/Flight/Freeze System that primarily encompasses mid-brain areas, especially the 
anterior cingulate, amygdala, medial hypothalamus and periaqueductal gray.  
In contrast, Generalized Anxiety Disorder (GAD) is thought to reflect altered 
functioning in the anxiety-mediating higher brain systems that govern responses to 
threats that require more complex responses than Fight/Flight/Freeze. These anxiety-
mediated responses are grouped under the label of risk assessment and typically 
include forward and backwards oscillations, environmental scanning and olfactory 
sampling (Blanchard et al., 2003). They are elicited by potential threats such as the 
odour of a predator that require approach. This in turn generates goal conflict and thus 
activates the Behavioural Inhibition System (BIS), which comprises structures 
ranging from the hippocampus to the dorsolateral prefrontal cortex (McNaughton & 
Corr, 2004). 
This analysis suggests that PD sufferers should display the greatest sensitivity 
to simple threats whereas GAD sufferers should display the greatest sensitivity to 
complex, goal conflict-related threats. However, preliminary attempts to test these 
hypotheses in healthy human subjects have produced mixed results. For example, 
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using a threat-scenario vignette methodology, it was found, as predicted, that 
individuals with high levels of self-reported fear (as measured by the Fear Survey 
Schedule, FSS; Wolpe & Lang, 1977) tended to select defensive responses entailing 
simple avoidance of threat (e.g., run away). However, contrary to the theory, high 
scorers on self-reported fear also tended to perceive threats in general as magnified, 
irrespective of threat type (Perkins et al. 2010). Using a behavioural measure of 
threat-sensitivity, known as the Joystick Operated Runway Task (JORT; Perkins et 
al., 2009; Figure 1A), it was found, again contrary to predictions, that the anti-anxiety 
drug lorazepam affects responses to simple threat (Perkins et al., 2013). 
 
------------------------- 
Figure 1 about here 
------------------------- 
The JORT measure of sensitivity to simple threat is known as Flight Intensity 
and is measured by subtracting average velocity in the one-way active avoidance trials 
that contained no threat of white noise (Figure 1C) from the average velocity in the 
one-way active avoidance trials with a threat of white noise (Figure 1D). JORT Flight 
Intensity therefore captures the degree to which threat (as indicated by the lightning 
flash icon) increased the velocity of the green dot cursor along the runway during one-
way avoidance of the red dot cursor. In line with predictions, a candidate genetic risk 
factor for PD was associated with JORT Flight Intensity in healthy humans (Perkins 
et al. 2011). 
The JORT measure of sensitivity to complex threat is known as Risk 
Assessment Intensity. This label stems from the original translated rodent task (the 
Mouse Defense Test Battery; MDTB, Griebel et al. 1997; Figure 1B). In the MDTB, 
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approach-withdrawal oscillation in the closed runway configuration is a component of 
rodent risk-assessment behaviour (Blanchard et al., 2003).  Approach-withdrawal 
oscillation has been linked to anxiety in rodents by the finding that this behaviour is 
sensitive to anxiolytic drugs (Blanchard et al., 1990). When the task was translated for 
human use, Risk Assessment Intensity was the label chosen to describe the degree to 
which threat (as indicated by the lightning flash icon) increased the magnitude of 
approach-withdrawal oscillation of the green dot when trapped between the two red 
dot cursors. JORT Risk Assessment Intensity has proved sensitive to lorazepam in 
three studies (Perkins et al., 2009; 2013, Lippold et al., in review). 
The face validity of the label of Risk Assessment Intensity may be considered 
limited, as in the human version of the task the approach-withdrawal oscillation 
serves no information-gathering function. Nevertheless, to remain consistent with the 
previously published research, the label has been retained in the present experiment 
with the proviso that the approach-withdrawal oscillation, labelled as Risk 
Assessment Intensity, should be viewed as echoing the hesitant oscillation behaviour 
that is a behavioural marker of goal conflict in rodents. 
Risk Assessment Intensity in the JORT was accordingly calculated as the 
standard deviation of the average velocity in the two-way active avoidance trials that 
contained no threat of white noise (Figure 1E) subtracted from the standard deviation 
of the average velocity in the two-way active avoidance trials with threat of white 
noise (Figure 1F). This method of measurement can be utilised even if average 
velocity is identical in the threat trials and in the non-threat trials because velocity is 
not the variable of interest in these trials, since it is not related to goal conflict. The 
key requirement for goal-conflict related behavioural measurement is that the 
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magnitude of oscillation (i.e., the S.D. of the velocity) differs between the two trial 
types as this signifies greater or lesser goal conflict. 
In order to provide a direct test of this theory in relevant clinical populations, 
we hypothesised that sensitivity to simple threat, as operationalised by scores on the 
constructs of JORT Flight Intensity and FSS Tissue Damage Fear, would be greatest 
in PD patients compared to other groups. Conversely, sensitivity to complex threat (as 
operationalised by scores on the constructs of JORT Risk Assessment Intensity and 




Patients were recruited from inpatient and outpatient services in and around Bonn, 
Germany, and were screened by an experienced clinical psychologist using the MINI 
International Neuropsychiatric Interview (Sheehan et al. 1998; German translation by 
Ackenheil et al. 1999). If both PD and GAD were present, the diagnosis that was 
more prominent based on our in-depth clinical assessment was used. Healthy controls 
were recruited from the community of the same geographical area and were screened 
for the exclusion criterion of any current or lifetime psychiatric diagnosis using the 
MINI. An additional exclusion criterion for all groups was a history of post-traumatic 
stress disorder (PTSD) as well as current substance abuse. 
 
2.2. Demographic and clinical assessments 
Demographic information (age, sex, level of education) was obtained from all 
participants using a self-report questionnaire. Handedness was assessed using the 
Edinburgh Handedness Inventory (Oldfield 1971). In patients, the global assessment 
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of functioning (GAF) scale of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV) was obtained as a measure of overall level of functioning. Illness 
duration was estimated retrospectively by the study clinician. All participants 
provided an estimate of verbal IQ (Mehrfachwahl-Wortschatz-Intelligenztest, MWT-
B; Lehrl et al. 1995), where possible scores range between 0 and 37, with higher 
scores indicating better verbal abilities. 
To measure the severity of GAD, PD and MDD symptoms in all groups, the 
Generalized Anxiety Disorder Questionnaire–IV (GAD-Q-IV) (Newman et al 2002), 
the Panic Disorder Severity Scale – Self-Report Version (PDSS-SR) (Shear et al 
1997) and the Beck Depression Inventory (BDI-II) (Hautzinger et al 2006) were 
administered. On each inventory, higher scores indicate a greater expression of the 
relevant dimension. 
Participants gave written, informed consent before participation, and the study 
was approved by the research ethics committee of the Faculty of Medicine at the 
University of Bonn (application number 139/14). 
 
2.3. JORT and FSS stimuli 
Threat-sensitivity was measured behaviourally using the Joystick Operated Runway 
Task (JORT; Perkins et al. 2009). The JORT (see Figure 1) is a computerized runway 
task that uses a force-sensing joystick to measure the intensity of avoidance of a 
simple pursuing threat (labelled Flight Intensity) and a more complex threat that 
requires approach (labelled Risk Assessment Intensity). The greater complexity of 
this trial type relates to the presence of two threat stimuli, one in front and one behind 
the cursor representing the participant. This creates a two-way active avoidance goal 
conflict; hence it is more complex than the trial types that only contain one threat 
         
Running head: Threat-sensitivity in affective disorders 
10 
 
stimulus and thus entail one-way active avoidance, but not goal conflict. The threat 
stimulus comprises an onscreen lightning flash icon that signifies the participant will 
receive a 115-dB white noise burst if they fail to evade the threat. The JORT contains 
48 trials each lasting seven seconds. In order to control for confounding factors, such 
as differences in participants’ hand-eye coordination, responses were measured 
without threat in 50% of trials, as signalled by the absence of the lightning flash icon 
on screen. 
  Self-report threat sensitivity was measured using a German translation of the 
Fear Survey Schedule (FSS; Wolpe & Lang, 1977). The FSS comprises 108 items that 
take the form of mini-vignettes describing a range of aversive situations/stimuli, such 
as “Receiving injections”, “Feeling rejected by others”, “Failure”, “Speaking in 
public, “Entering a room where other people are already seated”, “Prospects of a 
surgical operation” or “Human blood”. Participants use a scale of 0 (no fear) to 4 
(very much fear) to indicate how much they would be distressed by each item. The 
FSS items form two major factors that are usually labelled as Tissue Damage Fear and 
Social Fear (Arrindell, 1980). The former contains the FSS items that describe simple 
threats such as “Receiving injections” whereas the latter contains the FSS items that 
describe socially relevant threats of a more complex, abstract nature, such as “Failure” 
or “Feeling rejected by others”. 
2.4. Statistical analysis 
Data were analysed using IBM SPSS v25.0. The SPSS data and syntax files are 
available at https://osf.io/gzrp3. 
First, descriptive statistics were computed, and distributions were inspected 
for all variables. Chi squared tests were employed to confirm matching of groups in 
terms of sex, education, handedness and, for patient groups, medication status. 
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Univariate analysis of variance (ANOVA) was used to compare groups in 
demographic and psychometric (age, verbal intelligence) measures as well as clinical 
variables (GAD-Q-IV, PDSS-SR, BDI-II, duration of treatment).  
ANOVA was also used to compare groups on each dependent variable, i.e. 
scores on JORT Flight Intensity, JORT Risk Assessment Intensity, FSS Tissue 
Damage and FSS Social Fear. To reiterate, we were interested in investigating 
behaviourally and by self-report the sensitivity to simple and complex threats across 
anxiety disorders. Sensitivity to simple threats was operationalized using JORT Flight 
Intensity scores and FSS Tissue Damage Fear Scores. Sensitivity to complex threat 
was operationalized using JORT Risk Assessment Intensity scores and FSS Social 
Fear scores.  
Group (GAD, PD, MDD, CON) and Sex (male, female) were used as 
independent variables in these models. In order to confirm that any observed group 
differences hold beyond the possible confounds of age and intelligence, analysis of 
covariance (ANCOVA) was used for each JORT and FSS dependent variable with 
Group (GAD, PD, MDD, CON) and Sex (male, female) as independent variables and 
age and MWT-B score as covariates. 
In order to estimate overlap between behavioural and self-report dependent 
variables, Pearson correlations were carried out between JORT and FSS variables 
combined for the entire sample. 
For all analyses, the alpha level was set at .05. For post-hoc t-tests following 
ANOVA, Bonferroni correction of the alpha level was carried out on the basis of the 
number of comparisons following each ANOVA. 
 
3. Results 
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3.1. Descriptive statistics and intercorrelations 
One-hundred patients as well as 35 age and sex-matched healthy controls completed 
the study. The patients comprised 32 patients with Generalized Anxiety Disorder 
(GAD), 35 with Panic Disorder (PD) and 33 with Major Depression Disorder (MDD). 
Comorbidity with MDD occurred, as expected, for 23 GAD patients and 20 PD 
patients.  
Table 1 presents descriptive statistics of socio-demographic, clinical and 
dependent variables. For JORT variables, there was one missing value in each group 
due to technical problems. JORT Flight Intensity scores were positively skewed and, 
therefore, trimmed using a 90% winsorisation. Groups did not differ in age, sex 
distribution, handedness, education or verbal intelligence score (all p>.20). Patient 
groups did not differ in illness duration (p=.12) or medication status (p=.93). 
For GAD-Q-IV, there was a main effect of Group (F[3,131]=93.42, p<.001, 
ηp²=.68). Post-hoc tests showed that this effect was due to controls having lower 
scores than all patient groups (all p<.001), whereas the other comparisons were not 
significant after Bonferroni correction. 
For PDSS-SR, there was a main effect of Group (F[3,131]=38.96, p<.001, 
ηp²=.47). Post-hoc tests showed that this effect was due to controls having lower 
scores than all patient groups (all p<.001) and PD patients having higher scores than 
all other groups (all p<.001), whereas GAD and MDD groups did not differ 
significantly (p=.35). 
Finally, for BDI-II, there was a main effect of Group (F[3,131]=15.87, p<.001, 
ηp²=.27). Post-hoc tests showed that this effect was due to controls having lower 
scores than all patient groups (all p<.001), who did not differ significantly from each 
other. 
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Table 2 presents Pearson correlations between the threat sensitivity measures 
(JORT and FSS) and the clinical scales. There were no significant correlations 
between JORT scores and the clinical scales. There were significant correlations 
between both FSS subscales (Tissue Damage Fear and Social Fear) and all four 




Tables 1 and 2 about here 
-------------------------------- 
 
4.2. Group Differences in JORT Variables 
For JORT Flight Intensity, there was a main effect of Sex (F[1,123]=4.75, p=.03, 
ηp²=.04), indicating higher fear scores in females than males (Figure 2A). There was 
no main effect of Group (p>.99) and no Group by Sex interaction (p=.43). 
For JORT Risk Assessment Intensity, there was a main effect of Sex 
(F[1,123]=4.92, p=.03, ηp²=.04), indicating higher anxiety scores in females than 
males (Figure 2B). There was no main effect of Group (p=.58), but a Group by Sex 
interaction (F[3,123]=3.87, p=.01, ηp²=.09). The pattern underlying this interaction 
indicated that the difference in scores between males and females was stronger in PD 
patients (p=.004) than in other groups (all p>.07) (Figure 2B). Conversely, there were 
no pairwise Group differences for either level of Sex (all n.s. after Bonferroni 
correction). 
Including age and MWT-B verbal intelligence score as covariates yielded a 
qualitatively very similar pattern of results for both JORT variables. 
         




4.3. Group Differences in Fear Survey Schedule Variables 
For FSS Tissue Damage Fear, there was a main effect of Group (F[3,127]=12.06, 
p<.001, ηp²=.22) and a main effect of Sex (F[1,127]=4.20, p=.04, ηp²=.03), but no 
significant Group by Sex interaction (p=.25) (Figure 3A). The main effect of Sex 
indicated higher scores in females than males. The main effect of group derived from 
PD patients having higher scores than all other groups (all p<.001), but no further 
comparisons were significant at Bonferroni corrected alpha level (all p>.01). 
For FSS Social Fear, there was a main effect of Group (F[3,127]=14.42, 
p<.001, ηp²=.25) and a significant main effect of Sex (F[1,127]=6.29, p=.01, ηp²=.05), 
but no significant Group by Sex interaction (p=.23) (Figure 3B). The main effect of 
Sex indicated higher scores in females than males. The main effect of group derived 
from controls having lower scores than all patient groups (all p<.001), which did not 
differ from each other (all p>.03; n.s. at Bonferroni corrected alpha level). 
Including age and MWT-B verbal intelligence score as covariates yielded a 
qualitatively very similar pattern of results for both FSS variables. 
 
--------------------------------- 




In this study, we sought to investigate whether anxiety disorders can be distinguished 
from each other and from MDD by means of experimental behavioural and 
psychometric self-report measures of sensitivity to simple and complex threat. 
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Sensitivity to simple threat is theoretically linked to panic disorder (PD) and 
sensitivity to complex threat to generalised anxiety disorder (GAD). Our data do not 
support this hypothesis, as only one out of four a priori results were in favour of our 
expectations, namely that PD sufferers scored higher on FSS Tissue Damage Fear 
than all other groups, irrespective of sex. Since FSS Tissue Damage Fear is a 
theoretically pure measure of sensitivity to simple threat, this finding is consistent 
with the hypothesis that PD, more so than other anxiety or mood disorders, reflects 
altered functioning in basic, mid-brain systems that govern responses to such threats 
(McNaughton & Corr, 2004). However, contrary to our hypothesis, this result was not 
replicated in our behavioural measure of sensitivity to simple threat (JORT Flight 
Intensity), which instead showed that females scored significantly higher than males, 
irrespective of group. Again, contrary to our hypothesis, our behavioural measure of 
sensitivity to complex threat (JORT Risk Assessment Intensity) showed an 
unexpected result, as female PD patients scored higher than male PD patients, with 
this sex difference being more pronounced in the PD group than in the other groups. 
Finally, and once more contrary to our hypothesis, we found that FSS Social Fear was 
elevated in all patient groups compared to healthy controls, whereas patient groups 
did not differ from each other. In addition, across diagnostic groups, females had 
higher FSS Tissue Damage and Social Fear scores than males. 
Based on our results we suggest high sensitivity to social threat is associated 
with both anxiety disorders and depression, whereas high sensitivity to physical threat 
is associated with PD, in females at least. On a practical note, our data suggest that 
researchers requiring a quick, low-cost, general measure of threat-sensitivity that can 
screen for vulnerability to anxiety disorders and depression may wish to utilise the 
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FSS Social Fear scale, as this was the only measure that successfully distinguished all 
three groups of affective disorders patients from controls. 
At first glance, a similar argument could be made for scores on the personality 
dimension of neuroticism and numerous other general neuroticism-type 
questionnaires (Claridge & Davis 2001). However, the special feature of the FSS 
Social Fear scale is that it contains specific item content that measures difficulties 
with social situations. This is interesting as it hints that the over-arching core of the 
affective disorders that are studied in the paper is not hyper-reactivity in brain systems 
that process threat of physical harm but hyper-reactivity in brain systems that process 
threat of social harm. 
The possibility that sensitivity to threat of social harm is linked to 
vulnerability to anxiety and depression aligns with the recent finding that the observed 
overlap between anxiety and depression reflects a deficit in common executive 
function (Gustavson et al. 2018). This outcome appears to fit with the finding that 
social situations require abstract, socially-specific, complex cognitive processes that 
are linked to executive function (e.g., Carlson et al. 2015). This latter inference 
dovetails with data showing that susceptibility to depression is particularly influenced 
by proneness to loneliness (Cacioppo et al. 2010) and the finding that low 
conscientiousness (a plausible marker of impaired executive function) is associated 
with depression (Hakulinen et al. 2015). 
More generally, the present finding of an over-arching role for social fear in 
affective illness dovetails with the social risk hypothesis of depression (Allen & 
Badcock, 2006) which portrays depression as an adaptive response to perceived threat 
of social exclusion. According to this theory, depression increases sensitivity to 
indicators of social threat, boosts behaviours that signal reduced social threat and 
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increased need for social support and reduces the tendency to engage in risky, 
appetitive behaviours. 
The notion that sensitivity to physical threat may relate to vulnerability to 
anxiety disorders, particularly PD, can be reconciled with the finding in healthy 
humans that the anti-anxiety drug lorazepam reduces sensitivity to the threat of 
physical harm to oneself or inflicting it on others (Perkins et al. 2013a; 2013b). It also 
fits with epidemiological evidence that the personality trait of neuroticism is 
particularly elevated in both PD and GAD, compared to other anxiety disorders and 
depression (Weinstock & Whisman 2006). 
Given that we also observed that experimental behavioural and psychometric 
self-reported measures of threat-sensitivity were not significantly correlated in this 
sample, our data also suggest that threat-sensitivity is a complex, heterogeneous 
phenotype that requires fine-grained measurement at different levels of analysis, akin 
to other neuropsychiatric endophenotypes such as impulsivity and inhibitory 
dysfunction (Aichert et al 2012; Cyders & Coskunpinar 2011). The divergence in 
results across levels of analysis supports the importance of a multi-method approach 
such as the one that deployed in the present research. Future research may wish to add 
further levels of analysis, including the neural level (Perkins et al., 2019), in order to 
paint a more comprehensive picture of threat-sensitivity across the affective disorder 
spectrum.  
As a caveat it should be noted that this first patient study presented here is 
only one step towards further validating the JORT as a useful paradigm in this field, 
as experimental medicine research on human defensive behaviour is still at an early 
stage. Instead the present use of the JORT demonstrates in a preliminary and tentative 
way that it may be possible to deploy an objective behavioural measure of threat-
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sensitivity in clinical contexts that, when replicated and refined, have mainstream 
psychiatric relevance. 
JORT results showed a mixed pattern of significant sex differences, as females 
in general tended to score higher than males in both Flight Intensity but in Risk 
Assessment Intensity the sex differences were found only in PD patients, not controls. 
This pattern is at least partly in agreement with our self-report data which showed 
higher FSS Tissue Damage and FSS Social Fear scores in females than males. 
Therefore, and since JORT output comprises a difference score that is calculated by 
subtracting the intensity of avoidance behaviour under no threat from the intensity of 
avoidance behaviour under threat, the sex effect on JORT cannot be dismissed as an 
artefact of sex differences e.g. in physical strength or familiarity with computer 
gaming contexts. Instead, these data converge with the finding that female mammals 
tend to be more sensitive to threat than males (e.g., Day et al. 2016), and women are 
generally more susceptible to affective disorders than men (McLean et al 2011; 
Baxter et al. 2014). Whilst the JORT data are, therefore, difficult to interpret with 
certainty, they might indicate that the JORT can detect a clinically-relevant sex effect, 
similar perhaps to the sex differences we observed via self-report in the FSS Tissue 
Damage and Social Fear scales. Post hoc, the pattern of findings from the JORT fits a 
rodent study that was published after our study was completed which showed that, 
after learning, females were more sensitive than males to probabilistic punishment but 
less sensitive when punishment could be avoided with certainty (Chowdhury et al. 
2019). An indication of the likely neural seat of sex differences in threat-sensitivity is 
provided by a recent study showing that there are sex differences in the trajectories of 
development of two major brain systems that are involved in processing threat, 
namely the amygdala and hippocampus (Fish et al., 2019). 
         




4. 1. Limitations 
Some limitations of this study should be considered. First, the generalizability of the 
study findings is limited by the relatively small sample sizes. Post-hoc power analysis 
revealed for self-report anxiety measures a probability to detect a true between-group 
effect of about 1–β(Power)=0.40, using an effect size of d=0.19, α<.05, N=130 and 4 
groups. In order to demonstrate this effect conclusively, a total sample size of N=308 
and a critical F>2.63 would be required. The generalisability of the results is also 
limited by the relatively narrow focus of the anxiety disorders studied here, as the 
clinical category of anxiety disorders not only includes PD and GAD but also 
agoraphobia, social phobia and specific phobias. However, the theory that we tested 
in this paper (McNaughton & Corr, 2004) is based on rodent work and is focussed on 
PD and GAD. Hence, whilst other anxiety disorders are clinically important, they are 
beyond the scope of this paper. 
A further limitation is, that despite our efforts to obtain clearly diagnosed PD 
and GAD patients, the majority of patients in each group showed comorbidity with 
MDD. It should be noted, however, that in clinical reality, psychiatric diagnostic 
criteria do not carve nature by its joints, hence the observed comorbidity may indeed 
reflect the reality that clinicians tend to encounter in their consultations with patients. 
This is also shown in the results of the clinical scales we used for GAD, PD and MDD 
symptom severity, which failed to differentiate clearly between patient groups, apart 
from the PDSS which showed that PD patients scored significantly higher than other 
patient groups. This tendency to homogeneity in our three patient sample seems likely 
to have diminished any differences in threat-sensitivity that may exist between patient 
groups that show less overlap and comorbidity.  
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An additional limitation concerns the fact that a sizable portion of patients 
were treated with different drugs, although the percentage of medicated patients did 
not differ significantly between patient groups. Given that we have previously 
observed effects of acute drug challenges on JORT performance (Perkins et al 2009, 
2013), this issue allows for the possibility that clinical treatment may also have 
affected the JORT measurements obtained in this study. Future studies should 
therefore prioritise drug-naïve patients. 
 
5. Conclusions 
Our results suggest that self-reported elevated sensitivity to physical threat 
differentiates patients with panic disorder from those with depression and that 
elevated sensitivity to social threat is associated with vulnerability to both anxiety 
disorders and MDD. Our findings also point to the importance of characterising 
patient groups at different levels of analysis, with data obtained from questionnaires 
adding to the picture obtained from the behavioural JORT paradigm in this study. 
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Table 1: Descriptive Statistics of Demographic, Clinical and Dependent 
Variables 
 
 GAD (N=32) PD (N=35) MDD (N=33) CON (N=35) 
Age 35.66 (11.46) 34.49 (12.38) 33.12 (13.20) 34.77 (10.63) 
Sex (m/f) 11/21 8/27 10/23 12/23 
Handedness (r/l/m) 31/1/0 33/1/1 29/3/1 33/2/0 
MWT-B 29.31 (3.86) 27.37 (3.96) 28.55 (4.45) 29.23 (4.65) 
GAF 55.88 (6.85) 57.63 (7.97) 56.59 (6.38) 98.71 (2.53) 
GAD-Q-IV 9.11 (2.18) 8.42 (2.06) 7.61 (2.41) 1.56(1.73) 
PDSS-SR 5.91 (4.53) 10.29 (4.85) 7.61 (2.41) 0.06 (0.34) 
BDI-II 12.34 (11.92) 12.49 (10.24) 14.85 (7.28) 1.54 (3.53) 
Illness duration 9.48 (9.20) 6.05 (5.65) 6.42 (6.74) - 
Medicated (N) 18 20 20 - 
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JORT FI .20 (.39) .41 (.91) .21 (.39) .18 (.37) 
JORT RAI -.03 (.08) .01 (.11) -.01 (.09) -.004 (.08) 
FSS TDF 33.22 (19.86) 51.77 (21.21) 28.15 (16.33) 22.46 (13.51) 
FSS SF 52.54 (24.53) 60.43 (23.25) 49.21 (20.44) 25.03(16.91) 
 
Legend: Data represent means (standard deviations) for all variables except for sex, handedness and 
medication. Sex is given as number of males (m) and females (f). Handedness is given as number of 
right-handed (r), left-handed (l) or mixed-handed (m) participants. Illness duration is given in years. 
MWT-B is the Mehrfachwahl-Wortschatz-Intelligenztest verbal intelligence test score. GAF, Global 
Assessment of Functioning Scale. GAD-Q-IV, Generalized Anxiety Disorder Questionnaire–IV. 
PDSS-SR, Panic Disorder Severity Scale – Self-Report Version. BDI-II, Beck Depression Inventory. 
JORT, Joystick Operated Runway Task; FI, Flight Intensity; RAI, Risk Assessment Intensity; GAD, 
generalised anxiety disorder; PD, panic disorder; MDD, major depressive disorder; CON, controls; 
FSS, Fear Survey Schedule; TDF, Tissue Damage Fear; SF, Social Fear. 
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Table 2. Correlations 
---------------------------------------------------------------------------------------------------------------------------- 
Variable  1 2 3 4 5 6 7 8 9 
---------------------------------------------------------------------------------------------------------------------------- 
1. JORT FI -  
 
2. JORT RAI .183* -  
 
3. FSS TDF .078 .043 -  
 
4. FSS SF -.061 -.082 .703** -  
 
5. MWT-B -.092 -.039 -.071 .016 -  
 
6. GAF  -.037 .073 -.347** -.541** .041 -  
 
7. GAD-Q-IV .043 .042 .415** .652** -.054 -.795** -  
 
8. PDSS-SR -.138 .017 .411** .478** -.143 -.588** .557** -  
 




Legend: The table shows Pearson’s r coefficients in the combined sample. JORT, Joystick Operated 
Runway Task; FI, Flight Intensity; RAI, Risk Assessment Intensity; FSS, Fear Survey Schedule; TDF, 
Tissue Damage Fear; SF, Social Fear; MWT-B, Mehrfachwahl-Wortschatz-Intelligenz test verbal 
intelligence test score; GAF, Global Assessment of Functioning Scale; GAD-Q-IV, Generalized 
Anxiety Disorder Questionnaire–IV; PDSS-SR, Panic Disorder Severity Scale – Self-Report Version; 
BDI-II, Beck Depression Inventory.
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Figure 1: The Joystick Operated Runway Task (JORT) 
  
Legend for Figure 1: The picture shows the laboratory setup of the JORT as it was used in this study (A). It also shows the rodent task from 
which the JORT was developed (the Mouse Defense Test Battery; B). Also shown are the four trials types of the JORT: simple avoidance with 
no threat of white noise (C); simple avoidance with threat of white noise (D); two-way avoidance with no threat of white noise (E); two way 
avoidance with threat of white noise (F). 
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Legend for Figure 2: The figure shows the JORT performance as a function of group and sex. Error bars show 1 standard error of the mean. 
JORT, Joystick Operated Runway Task; GAD, generalised anxiety disorder; PD, panic disorder; MDD, major depressive disorder; CON, 
controls. (left) Flight Intensity; (right) Risk Assessment Intensity  
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Legend for Figure 3: The figure shows Fear Survey Schedule (FSS) Scores as a function of group and sex. Error bars show 1 standard error of 
the mean. GAD, generalised anxiety disorder; PD, panic disorder; MDD, major depressive disorder; CON, controls. (left) Tissue Damage Fear; 
(right) Social Fear 
         
